GMED
Globus Medical Inc. Class A
$85.36
+$0.55(+0.65%)
66
Overall
80
Value
45
Tech
73
Quality
Market Cap
$11.98B
Volume
828.85K
52W Range
$51.79 - $101.40
Target Price
$111.08
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $564.0M | $636.0M | $713.0M | $785.4M | $789.0M | $958.1M | $1.0B | $1.6B | $2.5B | $2.9B | ||
| Total Revenue | $564.0M | $636.0M | $713.0M | $785.4M | $789.0M | $958.1M | $1.0B | $1.6B | $2.5B | $2.9B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-134.7M | $-150.5M | $-159.4M | $180.0M | $217.5M | $239.2M | $263.7M | $548.2M | $1.0B | $957.8M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $429.3M | $485.5M | $553.6M | $605.4M | $571.6M | $718.9M | $759.1M | $1.0B | $1.5B | $2.0B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-275.1M | $-323.7M | $-384.2M | $433.4M | $460.1M | $546.9M | $531.2M | $886.7M | $1.3B | $1.5B | ||
| Research & Development | $44.5M | $43.7M | $55.5M | $60.1M | $84.5M | $97.3M | $73.0M | $124.0M | $163.8M | $147.2M | ||
| Research Expense | $44.5M | $43.7M | $55.5M | $60.1M | $84.5M | $97.3M | $73.0M | $124.0M | $163.8M | $147.2M | ||
| Selling, General & Administrative | $222.2M | $267.8M | $311.6M | $354.8M | $354.8M | $408.1M | $432.1M | $643.4M | $981.4M | $1.2B | ||
| Selling & Marketing Expenses | $222.2M | $267.8M | $-1.9M | $1.1M | $600.0K | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | $-1.5M | $-2.1M | $-3.0M | $354.8M | $354.8M | $408.1M | $432.1M | $643.4M | $981.4M | $1.2B | ||
| Promotion & Advertising | $-900.0K | $-1.5M | $-1.9M | $1.1M | $600.0K | -- | -- | -- | -- | -- | ||
| Salaries & Wages | $-11.7M | $-14.9M | $-22.2M | $26.4M | $27.3M | $31.3M | -- | -- | -- | -- | ||
| Depreciation & Amortization | $3.5M | $7.9M | $-32.0M | $13.8M | $16.8M | $18.5M | $17.7M | $51.0M | $119.4M | $118.2M | ||
| Depreciation & Amortization | $3.5M | $7.9M | $9.6M | $13.8M | $16.8M | $18.5M | $17.7M | $51.0M | $119.4M | $118.2M | ||
| Amortization | $3.5M | $7.9M | $9.6M | $13.8M | $16.8M | $18.5M | $17.7M | $51.0M | $119.4M | $118.2M | ||
| Other Operating Expenses | -- | -- | -- | $3.2M | $3.6M | $3.4M | -- | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $159.1M | $166.1M | $713.0M | $172.0M | $111.4M | $172.0M | $228.0M | $133.1M | $166.0M | $479.8M | ||
| EBITDA | $200.1M | $214.7M | $188.6M | $225.3M | $174.8M | $264.7M | $297.0M | $290.0M | $378.3M | $874.8M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | $-17.4M | $-14.0M | $-9.3M | $-14.2M | $-20.1M | $4.2M | $-7.1M | ||
| Net Non-Operating Interest Income/Expense | -- | -- | -- | $17.4M | $14.0M | $9.3M | $14.2M | $20.1M | $-4.2M | $7.1M | ||
| Other Income/Expense | $1.3M | $1.0M | $-4.0M | $-476.0K | $-793.0K | $-580.0K | $-7.5M | $2.1M | $-2.2M | $-121.1M | ||
| Other Special Charges | $563.0K | $571.0K | $5.6M | $476.0K | $793.0K | $580.0K | $1.9M | $-2.1M | $2.2M | $3.4M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | $-392.9M | $-537.9M | $-346.5M | -- | -- | -- | -- | $23.8M | $15.0M | ||
| Special Income Charges | -- | $392.9M | $537.9M | $-2.2M | $-9.0K | $-5.9M | $-2.3M | $-434.0K | $-23.8M | $-15.0M | ||
| Other Impairment Of Capital Assets | $-3.5M | $-516.0K | -- | -- | -- | -- | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $157.3M | $169.9M | $188.6M | $172.5M | $111.9M | $194.9M | $228.8M | $145.3M | $124.9M | $597.9M | ||
| Pre-Tax Income | $157.3M | $169.9M | $188.6M | $189.9M | $125.9M | $180.4M | $243.0M | $165.4M | $120.7M | $605.1M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $52.9M | $62.6M | $32.1M | $34.7M | $23.6M | $31.2M | $52.9M | $42.5M | $17.7M | $67.2M | ||
| NET INCOME | ||||||||||||
| Net Income | $104.3M | $107.3M | $680.8M | $155.2M | $102.3M | $149.2M | $190.2M | $122.9M | $103.0M | $537.9M | ||
| Net Income (Continuing Operations) | $104.3M | $107.3M | $680.8M | $155.2M | $102.3M | $149.2M | $190.2M | $122.9M | $103.0M | $537.9M | ||
| Net Income (Discontinued Operations) | $104.3M | $107.3M | $680.8M | $155.2M | $102.3M | $149.2M | $190.2M | $122.9M | $103.0M | $537.9M | ||
| Net Income (Common Stockholders) | $104.3M | $107.3M | $680.8M | $155.2M | $102.3M | $149.2M | $190.2M | $122.9M | $103.0M | $537.9M | ||
| Normalized Income | -- | -- | -- | $154.8M | $103.5M | -- | -- | -- | -- | $538.7M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-409.9M | $-474.1M | $-543.6M | $613.4M | $677.6M | $786.1M | $794.9M | $1.4B | $2.3B | $2.4B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $96.4M | $97.9M | $101.3M | $99.2M | $98.6M | $100.7M | $100.5M | $113.1M | $135.7M | $135.2M | ||
| Average Shares Outstanding (Diluted) | $96.4M | $97.9M | $101.3M | -- | $101.0M | $103.6M | $102.6M | $114.6M | $137.9M | $137.1M | ||
| Shares Outstanding | $96.0M | $96.7M | $98.7M | $99.8M | $99.8M | $101.6M | $100.3M | $135.4M | $137.5M | $135.3M | ||
| Basic EPS | $1.09 | $1.12 | $1.6 | $1.57 | $1.04 | $1.48 | $1.89 | $1.09 | $0.76 | $3.98 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $1.57 | $1.04 | $1.48 | $1.89 | $1.09 | $0.76 | $3.98 | ||
| Diluted EPS | $1.08 | $1.1 | $1.54 | $1.52 | $1.01 | $1.44 | $1.85 | $1.07 | $0.75 | $3.92 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $1.52 | $1.01 | $1.44 | $1.85 | $1.07 | $0.75 | $3.92 | ||
| OTHER METRICS | ||||||||||||
| Acquisition Expense | -- | -- | -- | $2.6M | $4.0M | $17.0M | $6.0M | $68.3M | $29.6M | $42.3M | ||
| Loss And Loss Adjustment Expected Incurred | $3.2M | $2.7M | $5.9M | -- | -- | -- | -- | -- | -- | -- | ||
| Net Operating Interest Income Expense | $3.1M | $6.6M | $13.3M | -- | -- | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | -- | -- | $2.2M | $9.0K | $5.9M | $2.3M | $434.0K | $314.0K | -- | ||
| Other Gand A | $-1.5M | $-2.1M | $-3.0M | $354.8M | $354.8M | $408.1M | $432.1M | $643.4M | $981.4M | $1.2B | ||
| Rent And Landing Fees | $-1.5M | $-2.1M | $-3.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $222.2M | $267.8M | $311.6M | -- | -- | -- | -- | -- | -- | -- | ||
| Restruct | -- | $-392.9M | $-537.9M | $-346.5M | -- | -- | -- | -- | $23.8M | $15.0M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GMED | $85.36 | +0.6% | 828.85K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Globus Medical Inc. Class A Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW